84
Views
1
CrossRef citations to date
0
Altmetric
Original Research

AVL9 is Upregulated in and Could Be a Predictive Biomarker for Colorectal Cancer

, ORCID Icon, ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 3123-3132 | Published online: 09 Apr 2021

References

  • Cheng L, Eng C, Nieman LZ, et al. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol. 2011;34(6):573–580. doi:10.1097/COC.0b013e3181fe41ed21217399
  • Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin. 2001;51(1):38–75. quiz 77–80. doi:10.3322/canjclin.51.1.38
  • Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.2160132133645
  • Linford A, Yoshimura S, Nunes Bastos R, et al. Rab14 and its exchange factor FAM116 link endocytic recycling and adherens junction stability in migrating cells. Dev Cell. 2012;22(5):952–966. doi:10.1016/j.devcel.2012.04.01022595670
  • Li Y, Xu J, Xiong H, et al. Cancer driver candidate genes AVL9, DENND5A and NUPL1 contribute to MDCK cystogenesis. Oncoscience. 2014;1(12):854–865. doi:10.1016/j.devcel.2012.04.01025621300
  • Zhang W, Wang J, Chai R, et al. Hypoxia-regulated lncRNA CRPAT4 promotes cell migration via regulating AVL9 in clear cell renal cell carcinomas. Onco Targets Ther. 2018;11:4537–4545. doi:10.2147/OTT.S16915530122945
  • Wang H, Yu M, Hu W, et al. Linc00662 promotes tumorigenesis and progression by regulating miR-497-5p/AVL9 axis in colorectal cancer. Front Genet. 2020;10:1385. doi:10.3389/fgene.2019.0138532038723
  • Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12(1):77. doi:10.1186/1471-2105-12-77
  • Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–241. doi:10.3322/caac.2114922700443
  • Harsay E, Schekman R. Avl9p, a member of a novel protein superfamily, functions in the late secretory pathway. Mol Biol Cell. 2007;18(4):1203–1219. doi:10.1091/mbc.e06-11-103517229886
  • Liang J, Sun T, Wang G, et al. Clinical significance and functions of miR-203a-3p/AVL9 axis in human non-small-cell lung cancer. Per Med. 2020;17(4):271–282. doi:10.2217/pme-2019-010832678693
  • Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol. 2009;10(7):445–457. doi:10.1038/nrm272019546857
  • Corbett AH. Post-transcriptional regulation of gene expression and human disease. Curr Opin Cell Biol. 2018;52:96–104. doi:10.1016/j.ceb.2018.02.01129518673
  • Polo S, Pece S, Di Fiore PP. Endocytosis and cancer. Curr Opin Cell Biol. 2004;16(2):156–161. doi:10.1016/j.ceb.2004.02.00315196558
  • Varewijck AJ, Janssen JA. Insulin and its analogues and their affinities for the IGF1 receptor. Endocr RElat Cancer. 2012;19(5):F63–F75. doi:10.1530/ERC-12-002622420005
  • Klagsbrun M, Eichmann A. A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev. 2005;16(4–5):535–548. doi:10.1016/j.cytogfr.2005.05.00215979925
  • Khan OM, Carvalho J, Spencer-Dene B, et al. The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer. J Clin Invest. 2018;128(4):1326–1337. doi:10.1172/JCI9732529346117
  • Dai K, Huang Y, Chen Z, Sun X, Yang L, Jiang Y. Kbtbd2 inhibits the cytotoxic activity of immortalized NK cells through down-regulating mTOR signaling in a mouse hepatocellular carcinoma model. Eur J Immunol. 2018;48(4):683–695. doi:10.1002/eji.20174728129331106
  • Taskesen E, Mishra A, van der Sluis S, et al; International FTD-Genomics Consortium. Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with amyotrophic lateral sclerosis by DNA-methylation and GWAS. Sci Rep. 2017;7(1):8899. doi:10.1038/s41598-017-09320-z28827549
  • Wang H, Wang Y, Qian L, et al. RNF216 contributes to proliferation and migration of colorectal cancer via suppressing BECN1-dependent autophagy. Oncotarget. 2016;7(32):51174–51183. doi:10.18632/oncotarget.943327203674
  • Gimeno-Valiente F, Riffo-Campos ÁL, Ayala G, et al. EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness. Sci Rep. 2020;10(1):3723. doi:10.1038/s41598-020-60476-732111877
  • Carpelan-Holmström M, Louhimo J, Stenman UH, et al. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 2002;22(4):2311–2316.12174919
  • Vacante M, Ciuni R, Basile F, Biondi A. The liquid biopsy in the management of colorectal cancer: an overview. Biomedicines. 2020;8(9):308. doi:10.1159/000494411